Scutellaria barbata D. Don (SBD) protects oxygen glucose deprivation/reperfusion-induced injuries of PC12 cells by up-regulating Nrf2

References

• Ni Z, Yao C, Zhu X, et al. Ailanthone inhibits non-small cell lung cancer cell growth through repressing DNA replication via downregulating RPA1. Br J Cancer. 2017;117:1621–1630.
   PubMed Web of Science ®Google Scholar
• Yang P, Sun D, Jiang F. Ailanthone promotes human vestibular schwannoma cells apoptosis and autophagy by down-regulation of miR-21. Oncol Res. 2018;26:941–948.
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhu L, Yang X, et al. Ailanthone induces G2/M cell cycle arrest and apoptosis of SGC7901 human gastric cancer cells. Mol Med Rep. 2017;16:6821–6827.
   PubMed Web of Science ®Google Scholar
• Peng S, Yi Z, Liu M. Ailanthone: a new potential drug for castration-resistant prostate cancer. Chinese J Cancer. 2017;36:25.
   PubMedGoogle Scholar
• Zhuo Z, Hu J, Yang X, et al. Ailanthone inhibits Huh7 cancer cell growth via cell cycle arrest and apoptosis in vitro and in vivo. Sci Rep. 2015;5:16185.
   PubMed Web of Science ®Google Scholar
• Kato T, Suzumura Y, Fukushima M, et al. Antitumor activity of novel ailanthone derivatives in vitro and in vivo. Anticancer Res. 1988;8:573–579.
   PubMed Web of Science ®Google Scholar
• Trino S, Lamorte D, Caivano A, et al. MicroRNAs as new biomarkers for diagnosis and prognosis, and as potential therapeutic targets in acute myeloid leukemia. Int J Mol Sci. 2018;19:E460.
   PubMed Web of Science ®Google Scholar
• Wang XX, Zhang R, Li Y. Expression of the miR-148/152 family in acute myeloid leukemia and its clinical significance. Med Sci Monit. 2017;23:4768–4778.
   PubMed Web of Science ®Google Scholar
• Elhamamsy AR, El Sharkawy MS, Zanaty AF, et al. Circulating miR-92a, miR-143 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia. Int J Mol Cell Med. 2017;6:77–86.
   PubMed Web of Science ®Google Scholar
• De Luca L, Trino S, Laurenzana I, et al. Knockdown of miR-128a induces Lin28a expression and reverts myeloid differentiation blockage in acute myeloid leukemia. Cell Death Dis. 2017;8:e2849.
   PubMed Web of Science ®Google Scholar
• Chen J, Zhou J, Chen X, et al. miRNA-449a is downregulated in osteosarcoma and promotes cell apoptosis by targeting BCL2. Tumor Biol. 2015;36:8221–8229.
   PubMedGoogle Scholar
• Sandbothe M, Buurman R, Reich N, et al. The microRNA-449 family inhibits TGF-beta-mediated liver cancer cell migration by targeting SOX4. J Hepatol. 2017;66:1012–1021.
   PubMed Web of Science ®Google Scholar
• Li Q, Peng J, Li X, et al. miR-449a targets Flot2 and inhibits gastric cancer invasion by inhibiting TGF-beta-mediated EMT. Diagn Pathol. 2015;10:202.
   PubMed Web of Science ®Google Scholar
• Luo W, Huang B, Li Z, et al. MicroRNA-449a is downregulated in non-small cell lung cancer and inhibits migration and invasion by targeting c-Met. PLoS One. 2013;8:e64759.
   PubMed Web of Science ®Google Scholar
• You J, Zhang Y, Li Y, et al. MiR-449a suppresses cell invasion by inhibiting MAP2K1 in non-small cell lung cancer. Am J Cancer Res. 2015;5:2730–2744.
   PubMed Web of Science ®Google Scholar
• Zhi-Kun S, Hong-Qi Y, Zhi-Quan W, et al. Erythropoietin prevents PC12 cells from beta-amyloid-induced apoptosis via PI3KAkt pathway. Transl Neurodegener. 2012;1:7.
   PubMedGoogle Scholar
• Okunade AL, Bikoff RE, Casper SJ, et al. Antiplasmodial activity of extracts and quassinoids isolated from seedlings of Ailanthus altissima (Simaroubaceae). Phytother Res. 2003;17:675–677.
   PubMed Web of Science ®Google Scholar
• Zheng Z, Zhao B. Astragalus polysaccharide protects hypoxia-induced injury by up-regulation of miR-138 in rat neural stem cells. Biomed Pharmacother. 2018;102:295–301.
   PubMed Web of Science ®Google Scholar
• Nalla AK, Gorantla B, Gondi CS, et al. Targeting MMP-9, uPAR, and cathepsin B inhibits invasion, migration and activates apoptosis in prostate cancer cells. Cancer Gene Ther. 2010;17:599–613.
   PubMed Web of Science ®Google Scholar
• Redondo-Munoz J, Ugarte-Berzal E, Garcia-Marco JA, et al. Alpha4beta1 integrin and 190-kDa CD44v constitute a cell surface docking complex for gelatinase B/MMP-9 in chronic leukemic but not in normal B cells. Blood. 2008;112:169–178.
   PubMed Web of Science ®Google Scholar
• Lazarides E. Intermediate filaments: a chemically heterogeneous, developmentally regulated class of proteins. Annu Rev Biochem. 1982;51:219–250.
   PubMed Web of Science ®Google Scholar
• Bouamrani A, Ramus C, Gay E, et al. Increased phosphorylation of vimentin in noninfiltrative meningiomas. PLoS One. 2010;5:e9238.
   PubMed Web of Science ®Google Scholar
• Cripe LD. Adult acute leukemia. Curr Probl Cancer. 1997; 21:1–64.
   PubMed Web of Science ®Google Scholar
• Whitman SP, Maharry K, Radmacher MD, et al. FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study. Blood. 2010;116:3622–3626.
   PubMed Web of Science ®Google Scholar
• Gerloff D, Grundler R, Wurm AA, et al. NF-kappaB/STAT5/miR-155 network targets PU.1 in FLT3-ITD-driven acute myeloid leukemia. Leukemia. 2015;29:535–547.
   PubMed Web of Science ®Google Scholar
• Zebisch A, Hatzl S, Pichler M, et al. Therapeutic resistance in acute myeloid leukemia: the role of non-coding RNAs. Int J Mol Sci. 2016;17:2080.
   PubMed Web of Science ®Google Scholar
• Wu D, Liu J, Chen J, et al. MiR-449a suppresses tumor growth, migration and invasion in non-small cell lung cancer by targeting HMGB1-mediated NF-kappaB signaling way. Oncol Res. 2018;27:227–235.
   PubMed Web of Science ®Google Scholar
• Chen J, Zhou J, Chen X, et al. miRNA-449a is downregulated in osteosarcoma and promotes cell apoptosis by targeting BCL2. Tumour Biol. 2015;36:8221–8229.
   PubMedGoogle Scholar
• Lobry C, Oh P, Mansour MR, et al. Notch signaling: switching an oncogene to a tumor suppressor. Blood. 2014;123:2451–2459.
   PubMed Web of Science ®Google Scholar
• Xu X, Zhao Y, Xu M, et al. Activation of Notch signal pathway is associated with a poorer prognosis in acute myeloid leukemia. Med Oncol. 2011;28:483–489.
   Web of Science ®Google Scholar
• Ono M, Takimoto R, Osuga T, et al. Targeting Notch-1 positive acute leukemia cells by novel fucose-bound liposomes carrying daunorubicin. Oncotarget. 2016;7:38586–38597.
   PubMed Web of Science ®Google Scholar
• Xu Q, Simpson SE, Scialla TJ, et al. Survival of acute myeloid leukemia cells requires PI3 kinase activation. Blood. 2003;102:972–980.
   PubMed Web of Science ®Google Scholar
• Jia HZ, Liu SL, Zou YF, et al. MicroRNA-223 is involved in the pathogenesis of atopic dermatitis by affecting histamine-N-methyltransferase. Cell Mol Biol (Noisy-le-Grand). 2018;64:103–107.
   PubMed Web of Science ®Google Scholar
• Feng Z, Qi S, Zhang Y, et al. Ly6G + neutrophil-derived miR-223 inhibits the NLRP3 inflammasome in mitochondrial DAMP-induced acute lung injury. Cell Death Dis. 2017;8:e3170.
   PubMed Web of Science ®Google Scholar
• Sharaf-Eldin WE, Kishk NA, Gad YZ, et al. Extracellular miR-145, miR-223 and miR-326 expression signature allow for differential diagnosis of immune-mediated neuroinflammatory diseases. J Neurol Sci. 2017;383:188–198.
   PubMed Web of Science ®Google Scholar
• Martinez SR, Ma Q, Dasgupta C, et al. MicroRNA-210 suppresses glucocorticoid receptor expression in response to hypoxia in fetal rat cardiomyocytes. Oncotarget. 2017;8:80249–80264.
   PubMedGoogle Scholar